title: [Neoadjuvant chemoradiotherapy in the combined treatment of patients with stage IB2-III cervical cancer].
abstract: There are provided own observations on the use of cisplatin and capecitabine in schemes of combined treatment of patients with cervical cancer. Their efficiency as radiosensitizing agents is showed. There are discussed possible indications for the use of cisplatin and capecitabine in cervical cancer patients with metastatic lymph nodes.
authors.forename: K D
authors.initials: KD
authors.lastname: Guseĭnov
authors.forename: S Ia
authors.initials: SIa
authors.lastname: Maksimov
authors.forename: A F
authors.initials: AF
authors.lastname: Urmancheeva
authors.forename: S B
authors.initials: SB
authors.lastname: Baranov
authors.forename: I V
authors.initials: IV
authors.lastname: Berlev
authors.forename: N A
authors.initials: NA
authors.lastname: Mikaia
mesh_terms: D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage* / Q000009:adverse effects*; D000069287:Capecitabine; D059248:Chemoradiotherapy / Q000009:adverse effects; D002945:Cisplatin / Q000008:administration & dosage / Q000009:adverse effects; D003841:Deoxycytidine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives; D006801:Humans; D008875:Middle Aged; D020360:Neoadjuvant Therapy / Q000379:methods*; D009367:Neoplasm Staging; D012189:Retrospective Studies; D012426:Russia / Q000453:epidemiology; D016019:Survival Analysis; D016896:Treatment Outcome; D002583:Uterine Cervical Neoplasms / Q000401:mortality / Q000473:pathology* / Q000628:therapy*
chemical_list: D003841:Deoxycytidine; D000069287:Capecitabine; D002945:Cisplatin; D005472:Fluorouracil